EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials

Mohammed A Elbahloul iD, Shrouk Ramadan iD, Eman E Labeeb iD, Shahed Aldalahmeh iD, Ahella Ismail A Mousa iD, Ahmed Elazab iD, Ahmed N Mohamed iD, Ahmad Elashery, Mehiar O El-Hamdani iD, Carl J Lavie iD, Gregg W Stone iD

Circulation: Cardiovascular Interventions · 2026-07 · 19 (7)

DOI: 10.1161/circinterventions.126.016601 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Circulation: Cardiovascular Interventions, 2026-07. Verfasst von Mohammed A Elbahloul und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Kafr El-Shaikh University, Egypt (M.A.E.). Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction, Time-to-Treatment. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The ideal timing for complete revascularization (CR) in patients with ST-segment–elevation myocardial infarction and multivessel disease is uncertain. This meta-analysis examined outcomes of immediate CR (ICR) versus staged CR (SCR). METHODS: Four databases were searched for randomized controlled trials that compared ICR and SCR in ST-segment–elevation myocardial infarction and multivessel disease. The primary end points of interest were short-term and long-term all-cause mortality. Outcomes are presented as risk ratios for short-term outcomes and incidence rate ratios for long-term outcomes with 95% CIs. RESULTS: The analysis included 9 randomized controlled trials in which 4213 patients were enrolled. Short-term all-cause mortality occurred in 2.0% of patients after ICR compared with 1.2% of patients after SCR (risk ratio, 1.66 [95% CI, 0.99–2.78], P =0.053; I 2 =0%). Short-term cardiac death was increased after ICR (risk ratio, 2.19 [95% CI, 1.08–4.44], P =0.03; I 2 =0%). At a median 1-year follow-up, all-cause mortality occurred in 4.7% of patients after ICR compared with 3.5% of patients after SCR (incidence rate ratio, 1.40 [95% CI, 0.97–2.03], P =0.07; I 2 =0%). No significant differences were identified between the ICR and SCR strategies at either short-term or long-term follow-up for other outcomes, including myocardial infarction, repeat revascularization, stent thrombosis, stroke, major bleeding, and the composite of major adverse cardiac or cerebrovascular events. CONCLUSIONS: In hemodynamically stable patients with ST-segment–elevation myocardial infarction and multivessel disease, an ICR strategy may increase short-term cardiac death compared with SCR, and the possibility of increased early and late all-cause mortality cannot be excluded. Despite some uncertainty, these results currently favor a staged CR strategy for most patients with ST-segment–elevation myocardial infarction and multivessel disease. REGISTRATION: URL: https://www.crd.york.ac.uk/PROSPERO/ ; Unique identifier: CRD420251163719.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseasePercutaneous Coronary InterventionST Elevation Myocardial InfarctionTime-to-TreatmentHumansRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

deathhumansmyocardial infarctionpercutaneous coronary interventionstents

Autor:innen und Institutionen

  • Faculty of Medicine, Kafr El-Shaikh University, Egypt (M.A.E.).
  • Faculty of Medicine, Ain Shams University, Cairo, Egypt (S.R.).
  • Faculty of Medicine, Al-Azhar University, Cairo, Egypt (E.E.L.).
  • Faculty of Medicine, Jordan University of Science and Technology, Al Ramtha, Jordan (S.A.).
  • Faculty of Pharmacy, Badr University in Cairo (BUC), Egypt (A.I.A.M.).
  • Faculty of Medicine, South Valley University, Qena, Egypt (A. Elazab).

ORCID-Profile: Mohammed A Elbahloul, Shrouk Ramadan, Eman E Labeeb, Shahed Aldalahmeh, Ahella Ismail A Mousa, Ahmed Elazab, Ahmed N Mohamed, Mehiar O El-Hamdani, Carl J Lavie, Gregg W Stone

Zitieren

APA

Elbahloul, M. A., Ramadan, S., Labeeb, E. E., Aldalahmeh, S., Mousa, A. I. A., Elazab, A., Mohamed, A. N., Elashery, A., El-Hamdani, M. O., Lavie, C. J., & Stone, G. W. (2026). Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials. Circulation: Cardiovascular Interventions, 19(7). https://doi.org/10.1161/circinterventions.126.016601

Vancouver

Elbahloul MA, Ramadan S, Labeeb EE, Aldalahmeh S, Mousa AIA, Elazab A, et al. Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials. Circulation: Cardiovascular Interventions. 2026;19(7). doi:10.1161/circinterventions.126.016601

BibTeX
@article{Elbahloul2026,
  author = {Elbahloul, Mohammed A and Ramadan, Shrouk and Labeeb, Eman E and Aldalahmeh, Shahed and Mousa, Ahella Ismail A and Elazab, Ahmed and Mohamed, Ahmed N and Elashery, Ahmad and El-Hamdani, Mehiar O and Lavie, Carl J and Stone, Gregg W},
  title = {Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {7},
  doi = {10.1161/circinterventions.126.016601}
}
Kostenlos starten →